Ledger.Open graph →
SEC Form D · Amendment · filed April 9, 2015

CARDEAS PHARMA Corp

Offering
$37.5M
Sold
$37.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Robert B. Degavre · Seattle, WADirectorAnthony B. Scullion · Seattle, WADirectorA. B. Montgomery · Seattle, WAExec · Director · PromoterPeter B. Moldt · Seattle, WADirectorKevin B. Kinsella · Seattle, WADirectorMelissa Yeager · Seattle, WAExec · PromoterAaron B. Davidson · Seattle, WADirectorJamshid Ashourian · Bakersfield, CAExec · Director · PromoterJoseph D. Rizzi · Sunnyvale, CADirectorScott Hempy · Mountain View, CADirectorPrashant Patel · Odessa, FLDirectorSuren Ajjarapu · Odessa, FLDirectorJohn Thompson · Sunnyvale, CAExec · Director · PromoterRay P. Wirta · San Diego, CAExec · Director · PromoterMark Leslie · Sunnyvale, CADirectorPablo D. Luther · Sunnyvale, CADirectorAshok D. Belani · Sunnyvale, CAExec · PromoterMichael D. Marks · Sunnyvale, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗